Pharma firms will progressively invest in internet and mobile-based technologies.

Over four fifths believe technology has improved access to health services.

Over 1,000 vaccines and therapies are in development, offering opportunities for manufacturers.

This is the second tranche of benchmarks after those for surgeon fees.

The hospital will provide obstetrics and gynaecology services.

The market is driven by a rise in aesthetic procedures and better patient outcomes.

The region accounts for more than 20% of the market globally.

The ballon sinus dilation segment dominates the market, but sinus stents are catching up fast.